Published in Clin Exp Immunol on June 01, 1994
Neutrophil-activating peptide-1/interleukin 8, a novel cytokine that activates neutrophils. J Clin Invest (1989) 10.59
Differential cytokine expression by human intestinal epithelial cell lines: regulated expression of interleukin 8. Gastroenterology (1993) 7.24
Structure and functional expression of a human interleukin-8 receptor. Science (1991) 4.74
Cloning of complementary DNA encoding a functional human interleukin-8 receptor. Science (1991) 3.85
Quantitative fecal indium 111-labeled leukocyte excretion in the assessment of disease in Crohn's disease. Gastroenterology (1983) 2.37
Indium 111-granulocyte scanning in the assessment of disease extent and disease activity in inflammatory bowel disease. A comparison with colonoscopy, histology, and fecal indium 111-granulocyte excretion. Gastroenterology (1986) 2.03
Localization of intestinal interleukin 1 activity and protein and gene expression to lamina propria cells. Gastroenterology (1993) 1.75
Expression of leukocyte adhesion molecules by mucosal mononuclear phagocytes in inflammatory bowel disease. Gastroenterology (1991) 1.62
IL-8 as an important chemoattractant for neutrophils in ulcerative colitis and Crohn's disease. Clin Exp Immunol (1994) 1.48
Scintigraphic assessment of bowel involvement and disease activity in Crohn's disease using technetium 99m-hexamethyl propylene amine oxine as leukocyte label. Gastroenterology (1988) 1.35
Neutrophil mucosal involvement is accompanied by enhanced local production of interleukin-8 in ulcerative colitis. Gut (1993) 1.33
Gut lavage fluid protein concentrations: objective measures of disease activity in inflammatory bowel disease. Gastroenterology (1993) 1.11
Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-kappa B. Nature (1995) 10.36
MyD88 is an adaptor protein in the hToll/IL-1 receptor family signaling pathways. Mol Cell (1998) 8.73
Inhibition of NF-kappa B by sodium salicylate and aspirin. Science (1994) 7.60
Phosphorylation of NF-kappa B p65 by PKA stimulates transcriptional activity by promoting a novel bivalent interaction with the coactivator CBP/p300. Mol Cell (1998) 7.03
DNA binding and I kappa B inhibition of the cloned p65 subunit of NF-kappa B, a rel-related polypeptide. Cell (1991) 6.63
Quantitation of intraepithelial lymphocytes in human jejunum. Gut (1971) 6.18
Frequency of "functional" gastrointestinal disorders. Lancet (1977) 5.73
NF-kappaB and the immune response. Oncogene (2006) 5.62
The transcriptional activity of NF-kappaB is regulated by the IkappaB-associated PKAc subunit through a cyclic AMP-independent mechanism. Cell (1997) 4.99
NICE guidance on CardioQ(TM) oesophageal Doppler monitoring. Anaesthesia (2011) 4.63
Mapping of the inducible IkappaB phosphorylation sites that signal its ubiquitination and degradation. Mol Cell Biol (1996) 4.56
Signal transduction through NF-kappa B. Immunol Today (1998) 4.54
Genetic analysis of autoimmune type 1 diabetes mellitus in mice. Nature (1991) 4.27
Selective inhibition of NF-kappaB activation by a peptide that blocks the interaction of NEMO with the IkappaB kinase complex. Science (2000) 4.04
Mapping genes for NIDDM. Design of the Finland-United States Investigation of NIDDM Genetics (FUSION) Study. Diabetes Care (1998) 3.99
I kappa B-beta regulates the persistent response in a biphasic activation of NF-kappa B. Cell (1995) 3.95
Rel-associated pp40: an inhibitor of the rel family of transcription factors. Science (1991) 3.76
Structure of NF-kappa B p50 homodimer bound to a kappa B site. Nature (1995) 3.59
Independent modes of transcriptional activation by the p50 and p65 subunits of NF-kappa B. Genes Dev (1992) 3.47
High-resolution manometry predicts the success of oesophageal bolus transport and identifies clinically important abnormalities not detected by conventional manometry. Neurogastroenterol Motil (2004) 3.44
Similarities in intestinal humoral immunity in dermatitis herpetiformis without enteropathy and in coeliac disease. Lancet (1990) 3.37
Intraepithelial lymphocytes of the small intestine. Gut (1977) 3.21
Concern Randomised controlled trial of cardioprotective diet in patients with recent acute myocardial infarction: results of one year follow up. BMJ (1992) 3.14
The effect of antigen deprivation on thymus-dependent and thymus-independent lymphocytes in the small intestine of the mouse. Clin Exp Immunol (1972) 3.09
Selective migration of lymphocytes within the mouse small intestine. Immunology (1974) 3.06
Toll-like receptor-mediated NF-kappaB activation: a phylogenetically conserved paradigm in innate immunity. J Clin Invest (2001) 3.04
A critical review of adaptive genetic variation in Atlantic salmon: implications for conservation. Biol Rev Camb Philos Soc (2007) 2.98
Changes in clinical features of coeliac disease in adults in Edinburgh and the Lothians 1960-79. Br Med J (Clin Res Ed) (1983) 2.91
Quantitative quality control in microarray image processing and data acquisition. Nucleic Acids Res (2001) 2.91
Increased capsaicin receptor TRPV1-expressing sensory fibres in irritable bowel syndrome and their correlation with abdominal pain. Gut (2008) 2.77
Metabolic defects in lean nondiabetic offspring of NIDDM parents: a cross-sectional study. Diabetes (1997) 2.76
Review article: dermatological complications of immunosuppressive and anti-TNF therapy in inflammatory bowel disease. Aliment Pharmacol Ther (2013) 2.74
Autoantibodies to tissue transglutaminase as predictors of celiac disease. Gastroenterology (1998) 2.68
Utility of adiponectin as a biomarker predictive of glycemic efficacy is demonstrated by collaborative pooling of data from clinical trials conducted by multiple sponsors. Clin Pharmacol Ther (2009) 2.60
Direct demonstration of P-selectin- and VCAM-1-dependent mononuclear cell rolling in early atherosclerotic lesions of apolipoprotein E-deficient mice. Circ Res (1999) 2.60
NF-kappa B and rel proteins in innate immunity. Adv Immunol (1995) 2.53
Immunological responses to fed protein antigens in mice. I. Reversal of oral tolerance to ovalbumin by cyclophosphamide. Immunology (1982) 2.50
Intestinal inflammation in cystic fibrosis. Arch Dis Child (2000) 2.46
Low bone mineral density in Crohn's disease, but not in ulcerative colitis, at diagnosis. Gastroenterology (1994) 2.45
Too many patients, too few cardiologists to care? Can J Cardiol (2006) 2.45
The effects of different component response requirements in multiple and concurrent schedules. J Exp Anal Behav (1978) 2.43
Cell-mediated immunity to gliadin within the small-intestinal mucosa in coeliac disease. Lancet (1975) 2.41
Prevalence and "incidence" of celiac disease in Edinburgh and the Lothian region of Scotland. Gastroenterology (1986) 2.34
Intraepithelial cells in the human intestinal mucosa. J Ultrastruct Res (1971) 2.31
Mechanisms of mutations inhibiting fusion and infection by Semliki Forest virus. J Cell Biol (1996) 2.25
Precipitins to dietary proteins in serum and upper intestinal secretions of coeliac children. Br Med J (1972) 2.25
Mortality in celiac disease. Gastroenterology (1989) 2.24
Failure to record variables of growth and development in children with inflammatory bowel disease. BMJ (1989) 2.22
Intra-articular bupivacaine: potentially chondrotoxic? Br J Anaesth (2009) 2.20
The NF-kappa B p50 precursor, p105, contains an internal I kappa B-like inhibitor that preferentially inhibits p50. EMBO J (1992) 2.19
ECSIT is an evolutionarily conserved intermediate in the Toll/IL-1 signal transduction pathway. Genes Dev (1999) 2.17
European evidence-based Consensus on the management of ulcerative colitis: Current management. J Crohns Colitis (2008) 2.14
Human intestinal mucosal mast cells: evaluation of fixation and staining techniques. J Clin Pathol (1981) 2.11
Higher blood flow and circulating NO products offset high-altitude hypoxia among Tibetans. Proc Natl Acad Sci U S A (2007) 2.07
Lymphocytes in Whipple's disease. Lancet (1968) 2.06
Microsatellites for linkage analysis of genetic traits. Trends Genet (1992) 2.05
Substrate nucleotide-determined non-templated addition of adenine by Taq DNA polymerase: implications for PCR-based genotyping and cloning. Biotechniques (1996) 2.02
Inhaled nitric oxide in patients with normal and increased pulmonary vascular resistance after cardiac surgery. Br J Anaesth (1994) 2.01
A glycine-rich region in NF-kappaB p105 functions as a processing signal for the generation of the p50 subunit. Mol Cell Biol (1996) 2.01
Hypersensitivity reactions in the small intestine. III. The effects of allograft rejection and of graft-versus-host disease on epithelial cell kinetics. Cell Tissue Kinet (1977) 2.00
Immunological responses to fed protein antigens in mice. II. Oral tolerance for CMI is due to activation of cyclophosphamide-sensitive cells by gut-processed antigen. Immunology (1983) 1.99
Inflammatory bowel disease and male infertility: effects of sulfasalazine and 5-aminosalicylic acid on sperm-fertilizing capacity and reactive oxygen species generation. Fertil Steril (1989) 1.98
Infliximab in moderately severe glucocorticoid resistant ulcerative colitis: a randomised controlled trial. Gut (2003) 1.95
Intraepithelial lymphocyte count and crypt hyperplasia measure the mucosal component of the graft-versus-host reaction in mouse small intestine. Gastroenterology (1982) 1.92
A case for a combined mother and child card. Indian Pediatr (1987) 1.92
Hypersensitivity in the small intestinal mucosa. V. Induction of cell-mediated immunity to a dietary antigen. Clin Exp Immunol (1981) 1.91
NF-kappa B activation by the pre-T cell receptor serves as a selective survival signal in T lymphocyte development. Immunity (2000) 1.91
Role of unphosphorylated, newly synthesized I kappa B beta in persistent activation of NF-kappa B. Mol Cell Biol (1996) 1.91
Hypermethylation of 14-3-3 sigma (stratifin) is an early event in breast cancer. Oncogene (2001) 1.89
Two distinct Raf domains mediate interaction with Ras. J Biol Chem (1995) 1.88
Rel/NF-kappa B and I kappa B proteins: an overview. Semin Cancer Biol (1997) 1.88
Anaerobic acidogenesis of wastewater sludge. J Water Pollut Control Fed (1975) 1.87
A randomized controlled study on the effectiveness of a multifaceted intervention program in the primary prevention of asthma in high-risk infants. Arch Pediatr Adolesc Med (2000) 1.85
Gastrointestinal amyloidosis in psoriatic arthritis. Ann Rheum Dis (1968) 1.81
A disease locus for hereditary haemorrhagic telangiectasia maps to chromosome 9q33-34. Nat Genet (1994) 1.81
Reactive oxygen species level in follicular fluid--embryo quality marker in IVF? Hum Reprod (2006) 1.80
Additional microsatellite markers for mouse genome mapping. Mamm Genome (1991) 1.79
Reduction of gastrointestinal protein loss by elemental diet in Crohn's disease of the small bowel. Gut (1981) 1.77
Familiality of quantitative metabolic traits in Finnish families with non-insulin-dependent diabetes mellitus. Finland-United States Investigation of NIDDM Genetics (FUSION) Study investigators. Hum Hered (1999) 1.76
Resuturing following penetrating keratoplasty: a retrospective analysis. Br J Ophthalmol (2008) 1.75
Hypersensitivity reactions in small intestine. I Thymus dependence of experimental 'partial villous atrophy'. Gut (1975) 1.74
Intraepithelial lymphocyte counts in small intestinal biopsies from children with diarrhoea. Acta Paediatr Scand (1976) 1.73
Ligation of CD40 stimulates the induction of nitric-oxide synthase in microglial cells. J Biol Chem (2001) 1.71
Primary biliary cirrhosis and coeliac disease: an association? Lancet (1978) 1.70
Interleukin 6 secreted from adipose stromal cells promotes migration and invasion of breast cancer cells. Oncogene (2009) 1.69
Growth and development of "antigen-free" grafts of foetal mouse intestine. J Pathol (1972) 1.68
A novel DNA recognition mode by the NF-kappa B p65 homodimer. Nat Struct Biol (1998) 1.68
Calmodulin activates intersubunit electron transfer in the neuronal nitric-oxide synthase dimer. J Biol Chem (2001) 1.68
Comparison of a low dose polyethylene glycol electrolyte solution with lactulose for treatment of chronic constipation. Gut (1999) 1.67
Cysticercosis causing single, small CT lesions in Indian patients with seizures. Lancet (1989) 1.66
Sirolimus in combination with tacrolimus and corticosteroids for the treatment of resistant chronic graft-versus-host disease. Br J Haematol (2005) 1.65
Socio-cultural factors affecting breast feeding and other infant feeding practices in an urban community. Indian Pediatr (1976) 1.64
Adult coeliac disease in hyposplenic patients. Lancet (1970) 1.63
Hypersensitivity reactions in the small intestine. 2. Effects of allograft rejection on mucosal architecture and lymphoid cell infiltrate. Gut (1976) 1.62
Intestinal antibody pattern of celiac disease: occurrence in patients with normal jejunal biopsy histology. Gastroenterology (1993) 1.61
Dissociation between systemic and mucosal humoral immune responses in coeliac disease. Gut (1991) 1.61
The use of malaria antibody tests in the prevention of transfusion-transmitted malaria. Vox Sang (2010) 1.60